Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway

Shumei Lia The General Ward, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaView further author information

Yajie Cuib Department of Clinical Pharmacy, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaView further author information

Min Lic Endocrine Department, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaView further author information

Wenting Zhangb Department of Clinical Pharmacy, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaView further author information

Xiaoxue Sund Drug Clinical Trial Center, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaView further author information

Zhaoxu Xine Department of Orthopaedics, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaView further author information

Jing Lid Drug Clinical Trial Center, The Third Affiliated Hospital of Qiqihar Medical University, Qiqihar, Heilongjiang, ChinaCorrespondence[email protected]
View further author information

show all

Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway

Citations (0)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date